Норвегія - норвезька - Statens legemiddelverk

pharma nord aps produktion - ginkgoblad - tablett, filmdrasjert

Норвегія - норвезька - Statens legemiddelverk

pharmacosmos - jern(iii)derisomaltose - injeksjons-/infusjonsvæske, oppløsning - 100 mg/ ml

Європейський Союз - норвезька - EMA (European Medicines Agency)

biogen netherlands b.v. - dimetylfumarat - multippel sklerose - immunsuppressive - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Європейський Союз - норвезька - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - multippel sklerose, relapsing-remitting - immunsuppressive - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Європейський Союз - норвезька - EMA (European Medicines Agency)

mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Європейський Союз - норвезька - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Європейський Союз - норвезька - EMA (European Medicines Agency)

teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Норвегія - норвезька - Statens legemiddelverk

sandoz a/s - dimetylfumarat - enterokapsel, hard - 240 mg

Норвегія - норвезька - Statens legemiddelverk

sandoz a/s - dimetylfumarat - enterokapsel, hard - 120 mg

Європейський Союз - норвезька - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).